微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 2.04% | 7.37% | -38.18% | 44/130 | 1.05% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 3.3% | -63.66% | 54.21% | 73/130 | 3.06% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 2.14% | -67.18% | -5.31% | 86/130 | 4.78% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | 2.26% | -42.93% | 18.95% | 74/130 | 3.07% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | 1.9% | -6.4% | -79.07% | 51/130 | 1.67% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 9.08% | -14.98% | 39.26% | 40/130 | 5.09% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 6.52% | -20.49% | 64.65% | 48/130 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 3.96% | -35.61% | 95.07% | 57/130 | 3.81% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 2.03% | -31.19% | -80.99% | 55/130 | 2.29% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | 10.68% | -56.94% | 30.24% | 63/130 | 13.41% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 8.2% | -49.32% | 33.33% | 66/130 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 6.15% | -50.68% | 108.47% | 61/130 | 9.3% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 2.95% | 2% | -88.1% | 55/130 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 24.8% | -15.62% | 53.28% | 27/130 | 17.49% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 16.18% | 2% | 29.75% | 36/130 | 15.94% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 12.47% | -4.52% | -57.57% | 36/130 | 11.54% | 热景生物 | 99.09% | 行业排名> |
| 2020-12-31 | 29.39% | -7.23% | 125.04% | 29/130 | 25.82% | 热景生物 | 57.63% | 行业排名> |
| 2020-06-30 | 13.06% | 2% | -58.78% | 35/130 | 15.16% | 中红医疗 | 168% | 行业排名> |
| 2019-12-31 | 31.68% | 78.48% | 78.48% | 13/130 | 14.38% | 圣湘生物 | 112.46% | 行业排名> |
| 2018-12-31 | 17.75% | 35.81% | 35.81% | 39/130 | 12.98% | 博拓生物 | 108.13% | 行业排名> |
| 2017-12-31 | 13.07% | 2% | 2% | 51/130 | 13.82% | 圣湘生物 | 29.33% | 行业排名> |